ILMN
70
-4
DVA
52
-2
HBAN
85
-2
PRU
77
-2
PM
58
4
EMC
60
-12
EXPD
37
-5
BK
74
-5
MTCH
57
-2
CI
52
3
JNJ
60
-2
RL
82
2
RF
74
-2
EOG
49
-3
BAX
50
2
CMG
54
4
FLR
42
-4
VIX
25
3
RRC
65
12
AN
52
-13
ILMN
70
-4
DVA
52
-2
HBAN
85
-2
PRU
77
-2
PM
58
4
EMC
60
-12
EXPD
37
-5
BK
74
-5
MTCH
57
-2
CI
52
3
JNJ
60
-2
RL
82
2
RF
74
-2
EOG
49
-3
BAX
50
2
CMG
54
4
FLR
42
-4
VIX
25
3
RRC
65
12
AN
52
-13
Financhill
Back

Palo Alto Networks, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
47

PANW
Palo Alto Networks, Inc.

Last Price:
$191.67
Seasonality Move:
8.47%
Sell
48

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$36.24
Seasonality Move:
6.21%
Sell
47
Palo Alto Networks, Inc. (PANW) is a Sell

Is Palo Alto Networks, Inc. a Buy, Sell or Hold?

  • The current Palo Alto Networks, Inc. [PANW] share price is $191.69. The Score for PANW is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • PANW is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.23. The Score for RARE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PANW Stock Price Chart

What is Palo Alto Networks, Inc.'s stock price today?

  • The Palo Alto Networks, Inc. share price today is $191.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PANW is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $36.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.

PANW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.44 Sell
Relative Strength Index (14 RSI): 42.47 Sell
Chaikin Money Flow: 1225575 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (186.67 - 206.59) Sell
Bollinger Bands (100): (183.48 - 211.96) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.99 Buy
Relative Strength Index (14 RSI): 61.17 Buy
Chaikin Money Flow: -31475 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.18 - 35.78) Buy
Bollinger Bands (100): (28.77 - 33.95) Buy

PANW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 194.19 Sell
20-day SMA: 192.69 Sell
50-day SMA: 205.11 Sell
200-day SMA: 192.15 Sell
8-day EMA: 192.77 Sell
20-day EMA: 195.24 Sell
50-day EMA: 199.56 Sell
200-day EMA: 193.83 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.32 Sell
20-day SMA: 34.36 Buy
50-day SMA: 33.41 Buy
200-day SMA: 33.75 Buy
8-day EMA: 35.88 Buy
20-day EMA: 34.85 Buy
50-day EMA: 33.54 Buy
200-day EMA: 34.8 Buy

Palo Alto Networks, Inc. Earnings Growth & PANW Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.04 per share, an increase this year of $0.49 per share, and an increase next year of $0.58 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Palo Alto Networks, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):